ES8706027A1 - Procedimiento de obtencion de una composicion para el tratamiento de vitiligo - Google Patents

Procedimiento de obtencion de una composicion para el tratamiento de vitiligo

Info

Publication number
ES8706027A1
ES8706027A1 ES553334A ES553334A ES8706027A1 ES 8706027 A1 ES8706027 A1 ES 8706027A1 ES 553334 A ES553334 A ES 553334A ES 553334 A ES553334 A ES 553334A ES 8706027 A1 ES8706027 A1 ES 8706027A1
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
topical pharmaceutical
treating vitiligo
vitiligo
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES553334A
Other languages
English (en)
Other versions
ES553334A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BELDA GALIANA MANUEL F
Original Assignee
BELDA GALIANA MANUEL F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BELDA GALIANA MANUEL F filed Critical BELDA GALIANA MANUEL F
Priority to ES553334A priority Critical patent/ES8706027A1/es
Priority to GB8628373A priority patent/GB2188233B/en
Publication of ES553334A0 publication Critical patent/ES553334A0/es
Publication of ES8706027A1 publication Critical patent/ES8706027A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

METODO PARA OBTENER UNA COMPOSICION PARA EL TRATAMIENTO DE VITILIGIO. CONSISTE EN: A) CALENTAR A LA TEMPERATURA DE FUSION NEO PCL AUTOEMULSIONABLE Y LANOLINA ANHIDRA, CON AGITACION Y EN PRESENCIA DE PROPILENGLICOL; B) MEZCLAR UREA, ACIDO SALICILICO, ACIDO RETINOICO Y ACETONICO DE TRIANCINOLONA; Y C) AÑADIR LA MEZCLA DE LA ETAPA B) A LA EMULSION RESULTANTE DE LA ETAPA A), CON AGITACION, Y EN PRESENCIA DE AGUA DESTILADA; DONDE EN LA ETAPA A) LA LANOLINA ANHIDRA SE EMPLEA EN UNA CANTIDAD DE 1 A 10%; Y DONDE EN LA ETAPA B) LA UREA SE EMPLEA EN CANTIDAD DE 3 A 40%; EL ACIDO SALICILICO DE 1 A 10%; EL ACIDO RETINOICO DE 0,025 A 0,3%; Y EL ACETONICO DE TRIANCINOLONA DE 0,025 A 2%. TIENE APLICACIONES FARMACEUTICAS PARA LA ENFERMEDAD DE VITILIGIO.
ES553334A 1986-03-24 1986-03-24 Procedimiento de obtencion de una composicion para el tratamiento de vitiligo Expired ES8706027A1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES553334A ES8706027A1 (es) 1986-03-24 1986-03-24 Procedimiento de obtencion de una composicion para el tratamiento de vitiligo
GB8628373A GB2188233B (en) 1986-03-24 1986-11-27 Topical pharmaceutical compositions for treating vitiligo.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES553334A ES8706027A1 (es) 1986-03-24 1986-03-24 Procedimiento de obtencion de una composicion para el tratamiento de vitiligo

Publications (2)

Publication Number Publication Date
ES553334A0 ES553334A0 (es) 1987-05-16
ES8706027A1 true ES8706027A1 (es) 1987-05-16

Family

ID=8491041

Family Applications (1)

Application Number Title Priority Date Filing Date
ES553334A Expired ES8706027A1 (es) 1986-03-24 1986-03-24 Procedimiento de obtencion de una composicion para el tratamiento de vitiligo

Country Status (2)

Country Link
ES (1) ES8706027A1 (es)
GB (1) GB2188233B (es)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2047456A1 (es) * 1992-07-31 1994-02-16 Postigo Herrando "composicion para la obtencion de un producto cosmetico y similar"
ES2083333A1 (es) * 1994-09-22 1996-04-01 Corral Begona Gozalo Crema para el tratamiento de la psoriasis.
ES2119726A1 (es) * 1997-03-20 1998-10-01 Reolid Manuel Sanchez Composicion de un producto para aplicacion corporal.
ES2156765A1 (es) * 1999-11-05 2001-07-01 Herrando Carlos Postigo Composicion de un producto aplicable a la piel.
ES2607630A1 (es) * 2016-03-09 2017-04-03 Paz LOPEZ PITA Crema tópica de clobetasol-17 propionato, urea y aceite de caléndula y procedimiento de fabricación

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4119170C2 (de) * 1991-06-11 2002-04-25 Geb Herber Miltner Mittel gegen Neurodermitis
CN1042896C (zh) * 1993-12-06 1999-04-14 广东医学院 外用皮质激素复方制剂
FR2718022B1 (fr) * 1994-04-01 1996-04-26 Roussel Uclaf Compositions cosmétiques ou dermatologiques et leur préparation.
KR100798853B1 (ko) * 2005-02-15 2008-01-28 (주)한국스티펠 레티노이드를 유효성분으로 하는 백반증 예방 및 치료용 약학적 조성물

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2047456A1 (es) * 1992-07-31 1994-02-16 Postigo Herrando "composicion para la obtencion de un producto cosmetico y similar"
ES2083333A1 (es) * 1994-09-22 1996-04-01 Corral Begona Gozalo Crema para el tratamiento de la psoriasis.
ES2119726A1 (es) * 1997-03-20 1998-10-01 Reolid Manuel Sanchez Composicion de un producto para aplicacion corporal.
ES2156765A1 (es) * 1999-11-05 2001-07-01 Herrando Carlos Postigo Composicion de un producto aplicable a la piel.
ES2607630A1 (es) * 2016-03-09 2017-04-03 Paz LOPEZ PITA Crema tópica de clobetasol-17 propionato, urea y aceite de caléndula y procedimiento de fabricación

Also Published As

Publication number Publication date
ES553334A0 (es) 1987-05-16
GB2188233A (en) 1987-09-30
GB8628373D0 (en) 1986-12-31
GB2188233B (en) 1990-07-18

Similar Documents

Publication Publication Date Title
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
ZA874635B (en) Novel anti-inflammatory agents,pharmaceutical compositions and methods for reducing inflammation
IE862404L (en) Hydroxamic acid derivatives
PT90764A (pt) Processo para a preparacaode um produto farmaceutico compreendendo um estrogenio e um anti-estrigenio e de composicoes farmaceuticas que os contem
PH21591A (en) Improved pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient and method of using said pharmaceutical composition
EP0259440A4 (en) METHOD FOR STIMULATING MELANOCYTES BY LOCALLY APPLYING ALPHA-MSH ANALOGS, AND COMPOSITIONS.
RU93047799A (ru) Композиции, содержащие ретиноевые кислоты и токоферол
EP0277428A3 (en) Cosmetic composition
EP0355152A4 (en) TOPICAL METRONIDAZOLE FORMULATIONS AND THE USE THEREOF AS MEDICINAL PRODUCTS.
NZ219374A (en) Topical pharmaceutical containing tamoxifen
DE68912195T2 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ATE77230T1 (de) Melatoninhaltige mittel sowie deren verwendungen.
ES8706027A1 (es) Procedimiento de obtencion de una composicion para el tratamiento de vitiligo
PT95697A (pt) Processo para a preparacao de composicoes farmaceuticas contendo substancias antiandrogenicamente activas
DE3788195D1 (de) DIBENZ[b,e]OXEPINDERIVATE, SOWIE ARZNEIMITTEL, DIE DIESE ALS AKTIVE MITTEL ENTHALTEN.
EP0249193A3 (en) Vehicle for topical application of pharmaceuticals
ES2006121A6 (es) Procedimiento para la preparacion de una composicion farmaceutica destinada al tratamiento de enfermedades cutaneas.
DE69018570T2 (de) Wasserlösliche Vitamin A-Zubereitungen und deren Verwendung bei der Hautbehandlung.
FI962506A (fi) Psoriasiksen hoito
GR3000330T3 (en) N,n-bis-(4-fluorophenyl) carbamoyl acetohydroxamic acid and pharmaceutical composition containing it
EP0211434A3 (de) Rektale Dosierungsformen für Ceftriaxon
ES2002917A6 (es) Procedimiento para la preparacion de farmacos dermoactivos
EP0173145A3 (en) Reduction of the toxic effects caused by anthraquinone drugs
DK192487A (da) Carbiovasculaere farmaceutiske praeparater, som er egnet til topisk indgivning

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990503